- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Jan. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global...
MORRISTOWN, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced a new program encouraging health...
- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global...
MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company...
CORONA, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced...
MORRISTOWN, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals (NYSE:WPI), a leader in generic and specialty branded...
MORRISTOWN, N.J., Aug. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today...
MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today...
MORRISTOWN, N.J., July 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded...
MORRISTOWN, N.J., July 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded...
MORRISTOWN, N.J., July 8 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded...
Former President, Health Care Services for CVS Caremark Corporation Brings Added Global Supply Chain Experience and Expertise to the Board...
CHICAGO, June 19 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments...
DALLAS, June 17 /PRNewswire/ -- Investment opinion and research company InvestorSoup.com announces the availability of free, detailed stock...
In the news release, New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability, issued yesterday, March 16, by Watson...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads